[go: up one dir, main page]

TW200738283A - Formulations of conjugated estrogens and bazedoxifene - Google Patents

Formulations of conjugated estrogens and bazedoxifene

Info

Publication number
TW200738283A
TW200738283A TW095123252A TW95123252A TW200738283A TW 200738283 A TW200738283 A TW 200738283A TW 095123252 A TW095123252 A TW 095123252A TW 95123252 A TW95123252 A TW 95123252A TW 200738283 A TW200738283 A TW 200738283A
Authority
TW
Taiwan
Prior art keywords
bazedoxifene
conjugated estrogens
formulations
salt
estrogens
Prior art date
Application number
TW095123252A
Other languages
English (en)
Inventor
Ramarao S Chatlapalli
Arwinder Nagi
Pelt Lawrence Van
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200738283(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200738283A publication Critical patent/TW200738283A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW095123252A 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene TW200738283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
TW200738283A true TW200738283A (en) 2007-10-16

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123252A TW200738283A (en) 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene

Country Status (19)

Country Link
US (1) US20070003623A1 (zh)
EP (1) EP1898888A2 (zh)
JP (1) JP2008545012A (zh)
KR (1) KR20080031037A (zh)
CN (1) CN101252921A (zh)
AR (1) AR054806A1 (zh)
AU (1) AU2006263638A1 (zh)
BR (1) BRPI0612586A2 (zh)
CA (1) CA2613102A1 (zh)
CR (1) CR9597A (zh)
EC (1) ECSP078057A (zh)
IL (1) IL188223A0 (zh)
NI (1) NI200700331A (zh)
NO (1) NO20080002L (zh)
PA (1) PA8684501A1 (zh)
PE (1) PE20070188A1 (zh)
RU (1) RU2395286C2 (zh)
TW (1) TW200738283A (zh)
WO (1) WO2007002823A2 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227966A1 (en) * 2004-04-08 2005-10-13 Wyeth Bazedoxifene acetate formulations
JP2010511062A (ja) * 2006-11-29 2010-04-08 ワイス エルエルシー エストロゲン／ｓｅｒｍおよびエストロゲン／プロゲスチン二層錠剤
JP2010515758A (ja) * 2007-01-12 2010-05-13 ワイス エルエルシー 錠剤中錠剤組成物
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
CA2775599A1 (en) 2009-10-27 2011-05-12 Wyeth Llc Bazedoxifene formulations with antioxidants
WO2011131943A2 (en) * 2010-04-20 2011-10-27 Cipla Limited Pharmaceutical compositions
EP2599252A4 (en) * 2010-07-29 2016-09-28 Entropic Communications Inc METHOD AND APPARATUS FOR ORTHOGONAL POLARIZATION AND CANCELLATION OF INTERFERENCE BETWEEN SATELLITES
EP2709597A2 (en) * 2011-05-13 2014-03-26 Emotional Brain B.V. Drug delivery system
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬雌激素组合物
SMT202200102T1 (it) 2015-06-18 2022-05-12 Estetra Srl Unità di dosaggio orodispersibile contenente un componente di estetrolo
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
TWI801561B (zh) * 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
IL147485A0 (en) * 1999-07-06 2002-08-14 Endorech Inc Pharmaceutical compositions containing a selective estrogen receptor modulator
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
UA85374C2 (en) * 2002-06-13 2009-01-26 Уайт bazedoxifene treatment regimen
RU2006132180A (ru) * 2004-04-07 2008-05-20 Вайет (Us) Кристаллический полиморф базедоксифен ацетата
PA8629201A1 (es) * 2004-04-07 2005-11-25 Wyeth Corp Polimorfo cristalino de acetato de bazedoxifeno
US20050227966A1 (en) * 2004-04-08 2005-10-13 Wyeth Bazedoxifene acetate formulations
AU2005233128A1 (en) * 2004-04-08 2005-10-27 Wyeth Bazedoxifene ascorbate as selective estrogen receptor modulator

Also Published As

Publication number Publication date
WO2007002823A2 (en) 2007-01-04
ECSP078057A (es) 2008-01-23
CR9597A (es) 2008-03-06
PA8684501A1 (es) 2007-01-17
CA2613102A1 (en) 2007-01-04
JP2008545012A (ja) 2008-12-11
NO20080002L (no) 2008-03-12
NI200700331A (es) 2009-02-16
AR054806A1 (es) 2007-07-18
IL188223A0 (en) 2008-03-20
AU2006263638A1 (en) 2007-01-04
EP1898888A2 (en) 2008-03-19
US20070003623A1 (en) 2007-01-04
PE20070188A1 (es) 2007-03-16
BRPI0612586A2 (pt) 2010-11-23
CN101252921A (zh) 2008-08-27
RU2007148071A (ru) 2009-08-10
KR20080031037A (ko) 2008-04-07
RU2395286C2 (ru) 2010-07-27
WO2007002823A3 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
IL179595A0 (en) Substituted indazoles, compositions containing same, preparation and use
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
TW200700406A (en) Novel thiophene derivatives
IL183102A0 (en) Betulin derivatives and pharmaceutical compositions containing the same
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
JO2578B1 (en) Compounds Theophene benzimidazole
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
TW200738670A (en) Novel thiophene derivatives
IL183044A0 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
IL184448A0 (en) Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
EP1637167A3 (en) New injectable formulations containing progesterone
PL1677818T3 (pl) Stabilne kompozycje wodne zawierające G-CSF
MXPA05008902A (es) Soluciones de drogas en mentol.
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
TW200719881A (en) Sedative effect-enabling agent and sedative aroma composition comprising the same
IL190063A (en) The history of cycloalkanes is preserved, their medicinal preparations and their uses
TW200505460A (en) Rosmarinic acid composition
WO2006087629A3 (en) Rapidly disintegrating composition of olanzapine
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
EP2168939A4 (en) 6,8,10-UNDECATRIENE-3-OL AND 6,8,10-UNDECATRIENE-4-OL, AND FRAGRANCE COMPOSITION